Spravato
Active substance: esketamine
SOLUTION · ESKETAMINE HYDROCHLORIDE 28 mg/.2mL
United StatesActive
Marketing holder: Janssen Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ESKETAMINE HYDROCHLORIDE · 28 mg/.2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United StatescontrolledSchedule: CIII
Source: openFDA NDC · record 01a1209d-6f9e-73d0-bce4-8a2f5dc64297;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50458-028
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIII
- Route
- NASAL
Sources
- product · openFDA NDC · 50458-028 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50458-028 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50458-028 · Verified 2026-10-09 · open in source